Display options
Share it on

Rare Dis. 2013 May 06;1:e24932. doi: 10.4161/rdis.24932. eCollection 2013.

Xeroderma Pigmentosum-Trichothiodystrophy overlap patient with novel XPD/ERCC2 mutation.

Rare diseases (Austin, Tex.)

Henrik H Kralund, Lilian Ousager, Nicolaas G Jaspers, Anja Raams, Erling B Pedersen, Else Gade, Anette Bygum

Affiliations

  1. Department of Dermatology and Allergy Centre; Odense University Hospital; Odense, Denmark.
  2. Department of Clinical and Medical Genetics; Odense University Hospital; Odense, Denmark.
  3. Department of Genetics; Erasmus Medical Center; Rotterdam, Netherlands.
  4. Departments of Medical Research and Medicine; University of Aarhus and Holstebro Hospital; Aarhus, Denmark.
  5. Department of Ophthalmology; Odense University Hospital; Odense, Denmark.

PMID: 25002996 PMCID: PMC3916142 DOI: 10.4161/rdis.24932

Abstract

Xeroderma Pigmentosum (XP), Trichothiodystrophy (TTD) and Cockayne Syndrome (CS) are rare, recessive disorders caused by mutational defects in the Nucleotide Excision Repair (NER) pathway and/or disruption of basic cellular DNA transcription. To date, a multitude of mutations in the XPD/ERCC2 gene have been described, many of which give rise to NER- and DNA transcription related diseases, which share certain diagnostic features and few overlap patients have been described. Despite increasing understanding of the roles of XPD/ERCC2 in mammalian cells, there is still weak predictability of somatic outcome from many of these mutations. We demonstrate a patient, believed to represent an overlap between XP and TTD/CS. In addition to other organ dysfunctions, the young man presented with Photosensitivity, Ichthyosis, Brittle hair, Impaired physical and mental development, Decreased fertility and Short stature (PIBIDS) suggestive of TTD, but lacking the almost patognomonic "tiger tail" banding of the hair under polarized light. Additionally, he developed basal cell carcinoma aged 28, as well as adult onset kidney failure, features normally not associated with TTD but rather XP/CS. His freckled appearance also suggested XP, but fibroblast cultures only demonstrated x2 UV-sensitivity with expected NER and TFIIH-activity decrease. Genetic sequencing of the XPD/ERCC2 gene established the patient as heterozygote compound with a novel, N-terminal Y18H mutation and a known C-terminal (TTD) mutation, A725P. The possible interplay between gene products and the patient phenotype is discussed.

Keywords: Trichothiodystrophy; XPD-gene; novel mutation; overlap syndrome; xeroderma pigmentosum

References

  1. Ophthalmology. 2011 Dec;118(12):2335-42 - PubMed
  2. Hum Mutat. 2008 Oct;29(10):1194-208 - PubMed
  3. Arch Dermatol. 2003 Sep;139(9):1189-92 - PubMed
  4. Am J Med Genet A. 2011 May;155A(5):1081-95 - PubMed
  5. Hum Mol Genet. 2001 Oct 15;10(22):2539-47 - PubMed
  6. J Med Genet. 2008 Oct;45(10):609-21 - PubMed
  7. J Exp Med. 2009 Dec 21;206(13):3031-46 - PubMed
  8. Hum Mutat. 1997;9(6):519-25 - PubMed
  9. Neuroscience. 2007 Apr 14;145(4):1388-96 - PubMed
  10. Mol Cell. 1998 Jun;1(7):981-90 - PubMed
  11. DNA Repair (Amst). 2002 Dec 5;1(12):1027-38 - PubMed
  12. Clin Nephrol. 1988 Apr;29(4):206-9 - PubMed
  13. Nat Genet. 2001 Mar;27(3):299-303 - PubMed
  14. J Am Acad Dermatol. 2001 Jun;44(6):891-920; quiz 921-4 - PubMed
  15. Hum Mol Genet. 2002 Nov 1;11(23):2919-28 - PubMed
  16. Am J Hum Genet. 2007 Mar;80(3):457-66 - PubMed
  17. J Am Acad Dermatol. 2005 Feb;52(2):224-32 - PubMed
  18. DNA Repair (Amst). 2010 May 4;9(5):506-16 - PubMed
  19. Nucleic Acids Res. 2009 Mar;37(4):e31 - PubMed

Publication Types